California State Teachers Retirement System (CalSTRS)’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,940
Closed -$4.56K 2987
2025
Q1
$4.56K Hold
2,940
﹤0.01% 2933
2024
Q4
$6.29K Hold
2,940
﹤0.01% 2964
2024
Q3
$12.8K Buy
2,940
+249
+9% +$1.35K ﹤0.01% 2797
2024
Q2
$12.5K Buy
+2,691
New +$14.4K ﹤0.01% 2793
2022
Q2
Sell
-9,999
Closed -$28K 3149
2022
Q1
$28K Sell
9,999
-2,287
-19% -$8.35K ﹤0.01% 3142
2021
Q4
$65K Sell
12,286
-18,035
-59% -$126K ﹤0.01% 3105
2021
Q3
$257K Sell
30,321
-1,074
-3% -$10.6K ﹤0.01% 2647
2021
Q2
$383K Buy
31,395
+4,032
+15% +$79.7K ﹤0.01% 2785
2021
Q1
$664K Hold
27,363
﹤0.01% 2391
2020
Q4
$877K Hold
27,363
﹤0.01% 2119
2020
Q3
$827K Buy
27,363
+9,022
+49% +$275K ﹤0.01% 1971
2020
Q2
$773K Hold
18,341
﹤0.01% 1997
2020
Q1
$458K Buy
+18,341
New +$558K ﹤0.01% 2110

Other funds holding BDTX

California State Teachers Retirement System (CalSTRS)'s BDTX Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Black Diamond Therapeutics (BDTX) in Q2 2025, closing a stake of 2,940 shares — an estimated $4.56K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in BDTX in Q1 2020 and held it in 13 quarters. The position peaked at $877K in Q4 2020. 94 funds tracked by Wall St. Rank hold BDTX as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Black Diamond Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 2,940 Black Diamond Therapeutics shares in Q2 2025, an estimated $4.56K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 13 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Black Diamond Therapeutics position peaked at $877K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.